Diabetes Care 31:517521 Glimelius B, Manojlovic N, Pfeiffer P, Mosidze B, Kurteva G, Karlberg M, Mahalingam D, Buhl Jensen P, Kowalski J, Bengtson M, Nittve M, Nsstrm J (2018) Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx): a placebo-controlled randomised phase II study (PLIANT)
The use of this approach emphasizes the importance of patient engagement, education, and ongoing communication in a patient-centric model of care to ensure the successful integration of oral semaglutide into the daily lives of individuals managing T2D
Bankir, L., Bouby, N., Trinh-Trang-Tan, M.-M., Ahloulay, M
DOI: 10.1155/2020/5197201